People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intellicyt Corp | — | Biotechnology | Series A | $13.8M | $196.8M | 2013 |
J. Michael Schafer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Michael Schafer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ball | 1 | 10 |
| Gregory Johnson | 1 | 8 |
| R. Terry Dunlay | 1 | 3 |
| Jack T. Ball | 1 | 2 |
| Matt Warta | 1 | 2 |
| Bo Saxberg | 1 | 2 |
| H. Ray Radosevich | 1 | 1 |
| Tim Ray Petersen | 1 | 1 |
| H. Raymond Radosevich | 1 | 1 |
| Thomas T. Duensing | 1 | 1 |
| Dan T. Kidle | 1 | 1 |
| Dennis T. Hynson | 1 | 1 |
| Janette T. Phi | 1 | 1 |
| Bo E.H. Saxberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.